McBreen Michael J.'s Form 4 filing
Integra Lifesciences Holdings CorpIART · filed Nov 8, 2021
- Accession no.
- 0001209191-21-063408
- Filed
- Nov 8, 2021
- Trade date
- Nov 5, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $247.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McBreen Michael J.CIK 0001814943 | Officer (EVP & President, CSS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2021 | Common Stock | SSaleDisposed | −3,450 | $71.59F1 | −$246,985.5 | 9,737 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price shown above represents the weighted average price of the shares sold. The range of sale prices was $71.58 to $71.60.
Referenced by the price of 1 transaction in Table I.